Africa accounts for less than two per cent of the 690 million Covid-19 vaccines administered globally so far. "Although progress is being made, many African countries have barely moved beyond the starting line," Matshidiso Moeti, WHO regional director for Africa said in a statement issued in Nairobi.
Matshidiso Moeti said limited access to vaccines could derail efforts to contain the pandemic in the continent amid threats posed by a third wave of infections, Xinhua news agency reported on Friday.
"Limited stocks and supply bottlenecks are putting Covid-19 vaccines out of reach of many people in this region. Fair access to vaccines must be a reality if we are to collectively make a dent on this pandemic," she added.
Statistics from WHO indicate that 45 African countries have received Covid-19 vaccine, 43 have begun inoculating high-risk groups while nearly 13 million of the 31.6 million doses delivered so far have been administered.
Moeti said that vaccine rollout in the continent has not been uniform since ten countries have received 93 per cent of the doses while logistical and personnel hiccups are undermining mass inoculation against the coronavirus.
"Africa is already playing Covid-19 vaccination catch-up, and the gap is widening. While we acknowledge the immense burden placed by the global demand for vaccines, inequity can only worsen scarcity," said Moeti.
"More than a billion Africans remain on the margins of this historic march to overcome the pandemic," she added.
However, Africa could still manage to vaccinate at least 20 percent of its population by the end of this year if governments prioritize targeted interventions like training of health workers, improving cold chain infrastructure and public awareness.
According to African Centers for Disease Control (CDC) and Prevention, Morocco has emerged as the leader in Covid-19 vaccination in the continent, having administered four million doses to cover nearly 11 per cent of its population. Only Seychelles and Mauritius have acquired enough vaccine doses to reach the 20 per cent vaccination target.
--IANS
int/
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)